Get the Stockscreener App
0.5926
3.96%
0.0226
Fibrobiologics Inc stock is traded at $0.5926, with a volume of 187.73K.
It is up +3.96% in the last 24 hours and down -11.18% over the past month.
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
See More
Previous Close:
$0.57
Open:
$0.5814
24h Volume:
187.73K
Relative Volume:
0.44
Market Cap:
$24.82M
Revenue:
-
Net Income/Loss:
$-17.78M
P/E Ratio:
-1.079
EPS:
-0.5492
Net Cash Flow:
$-10.52M
1W Performance:
+0.78%
1M Performance:
-11.18%
6M Performance:
-47.32%
1Y Performance:
-62.49%
1-Day Range:
$0.57
$0.6073
1-Week Range:
$0.5605
$0.63
52-Week Range:
$0.5282
$4.41
Fibrobiologics Inc Stock (FBLG) Company Profile
Name
Fibrobiologics Inc
Sector
Industry
Phone
281-671-5150
Address
455 E. MEDICAL CENTER BLVD, HOUSTON
Compare FBLG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FBLG
Fibrobiologics Inc
|
0.5926 | 25.85M | 0 | -17.78M | -10.52M | -0.5492 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.60 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
600.84 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.60 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
662.45 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
312.09 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Fibrobiologics Inc Stock (FBLG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-30-24 | Initiated | H.C. Wainwright | Buy |
| Sep-24-24 | Initiated | Maxim Group | Buy |
Fibrobiologics Inc Stock (FBLG) Latest News
Can FibroBiologics Inc. ride the EV waveWeekly Risk Report & Stock Portfolio Risk Control - thegnnews.com
Using data models to predict FibroBiologics Inc. stock movementJuly 2025 EndofMonth & Reliable Price Breakout Alerts - Newser
How to interpret RSI for FibroBiologics Inc. stockJuly 2025 Closing Moves & Verified Momentum Stock Ideas - Newser
Regression Model Predicts Rangebound Movement in FibroBiologics Inc.Trade Entry Report & Fast Exit and Entry Strategy Plans - Newser
Earnings visualization tools for FibroBiologics Inc.2025 Pullback Review & Expert Curated Trade Ideas - Newser
How institutional ownership impacts FibroBiologics Inc. stock2025 Technical Patterns & Safe Capital Growth Trade Ideas - Newser
Real time breakdown of FibroBiologics Inc. stock performanceWeekly Risk Summary & Proven Capital Preservation Tips - Newser
What MACD signals say about FibroBiologics Inc.2025 Market Outlook & Weekly High Momentum Picks - Newser
How to forecast FibroBiologics Inc. trends using time series2025 Institutional Moves & Weekly Market Pulse Updates - Newser
Published on: 2025-08-20 02:23:18 - Newser
Smart tools for monitoring FibroBiologics Inc.’s price actionWeekly Gains Summary & Risk Adjusted Buy/Sell Alerts - Newser
Historical volatility pattern of FibroBiologics Inc. visualizedTake Profit & Low Drawdown Investment Ideas - Newser
Real time alert setup for FibroBiologics Inc. performanceWeekly Volume Report & Real-Time Volume Analysis Alerts - Newser
Visualizing FibroBiologics Inc. stock with heatmapsQuarterly Profit Review & High Accuracy Buy Signal Tips - Newser
Is FibroBiologics Inc. reversing from oversold territoryJuly 2025 Summary & Verified Technical Signals - Newser
How to read the order book for FibroBiologics Inc.Trade Signal Summary & Consistent Profit Alerts - Newser
Will earnings trigger a reversal in FibroBiologics Inc.2025 Retail Activity & Free Real-Time Market Sentiment Alerts - Newser
Ranking FibroBiologics Inc. among high performing stocks via toolsMarket Performance Recap & Safe Entry Momentum Tips - Newser
Using fundamentals and technicals on FibroBiologics Inc.Market Movement Recap & Safe Entry Momentum Tips - Newser
Price action breakdown for FibroBiologics Inc.Weekly Investment Recap & AI Based Buy and Sell Signals - Newser
Tools to monitor FibroBiologics Inc. recovery probabilityQuarterly Earnings Summary & Free Accurate Trade Setup Notifications - Newser
Can FibroBiologics Inc. expand into new marketsWeekly Profit Summary & Accurate Trade Setup Notifications - thegnnews.com
What the charts say about FibroBiologics Inc. today2025 Institutional Moves & Daily Chart Pattern Signals - Newser
FibroBiologics Inc. stock trend outlook and recovery path2025 Volume Leaders & AI Forecasted Entry and Exit Points - Newser
FibroBiologics Inc. Rebounds From Oversold Zone — Now What2025 Biggest Moves & Weekly High Return Opportunities - newsimpact.co.kr
Using data filters to optimize entry into FibroBiologics Inc.Sell Signal & Daily Growth Stock Tips - Newser
Applying Elliott Wave Theory to FibroBiologics Inc.2025 Bull vs Bear & Daily Entry Point Trade Alerts - Newser
Multi asset correlation models including FibroBiologics Inc.Weekly Stock Report & AI Forecasted Entry/Exit Points - Newser
Using economic indicators to assess FibroBiologics Inc. potentialTrade Analysis Report & Expert Curated Trade Setup Alerts - Newser
Custom strategy builders for tracking FibroBiologics Inc.Weekly Market Outlook & Free Weekly Chart Analysis and Trade Guides - Newser
Strategies to average down on FibroBiologics Inc.2025 Price Targets & Verified Chart Pattern Signals - Newser
Is FibroBiologics Inc. a cyclical or defensive stockJuly 2025 Intraday Action & Low Volatility Stock Suggestions - thegnnews.com
Key metrics from FibroBiologics Inc.’s quarterly dataMarket Performance Report & Fast Gain Stock Trading Tips - Newser
Building trade automation scripts for FibroBiologics Inc.2025 Top Gainers & High Yield Stock Recommendations - Newser
Fibrobiologics Inc Stock (FBLG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.99%
0.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):